Related Experiment Video

Updated: Jan 28, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K

Immunotherapy for small cell lung cancer: mechanisms of resistance

Gerhard Hamilton1, Barbara Rath1

  • 1a Department of Surgery , Medical University of Vienna , Vienna , Austria.

Expert Opinion on Biological Therapy
|March 12, 2019
PubMed
Abstract

Insights

Checkpoint inhibitors show limited efficacy in small cell lung cancer (SCLC) due to immune resistance mechanisms. However, selected SCLC patients may still achieve long-term survival with immunotherapy.

Area of Science:

  • Oncology
  • Immunotherapy
  • Cancer Research

Background:

  • Small cell lung cancer (SCLC) is aggressive with poor prognosis.
  • SCLC is linked to smoking and has a high mutation rate.
  • Checkpoint inhibitors are being investigated for SCLC treatment.

Purpose of the Study:

  • To evaluate the efficacy of checkpoint inhibitors in SCLC.
  • To identify mechanisms of resistance to immunotherapy in SCLC.
  • To understand factors influencing long-term survival in SCLC patients treated with immunotherapy.

Main Methods:

  • Review of clinical trial data for checkpoint inhibitors in SCLC.
  • Analysis of factors limiting immunotherapy efficacy.
  • Discussion of resistance mechanisms relevant to SCLC.

Main Results:

  • Clinical trials show lower success rates for checkpoint inhibitors in SCLC compared to NSCLC.
  • Factors like low PD-L1 and MHC expression, poor T-cell infiltration, and immunosuppressive tumor microenvironments limit efficacy.
  • Despite challenges, some SCLC patients achieve long-term survival with anti-PD-1/PD-L1 and CTLA-4 agents.

Conclusions:

  • Immunotherapy in SCLC is effective only in highly selected patients.
  • Patient selection criteria may include good performance status and specific, yet unknown, preconditions.
  • Further research is needed to optimize immunotherapy strategies for SCLC.
Keywords:
PD-L1Small cell lung cancercheckpoint inhibitoimmunotherapytumor microenvironment

More Related Videos

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

30.5K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

379

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.5K